Articles

MOR stock results show that MorphoSys missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. More

Sound Financial Bancorp just reported results for the first quarter of 2024. More

Cyclacel Pharmaceuticals stock is up on Tuesday with heavy trading of CYCC shares after the company withdrew a public offering. More

Our coverage for Tuesday starts with a dive into the biggest pre-market stock movers traders will want to keep an eye on today! More

For investors looking for cryptos to sell ahead of what could be a volatile run to the end of the year, here are three to consider. More

Discover how these stocks may progress in consumer staples, health care, and tech sectors and outperform the S&P 500. More

Investors interested in diversifying their portfolios should consider these three 3D printing stocks as part of the process. More

Subscriber Sign in